These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21365779)
1. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety. Rosenfeld M; Davis S; Brumback L; Daniel S; Rowbotham R; Johnson R; McNamara S; Jensen R; Barlow C; Ratjen F Pediatr Pulmonol; 2011 Jul; 46(7):666-71. PubMed ID: 21365779 [TBL] [Abstract][Full Text] [Related]
2. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Subbarao P; Balkovec S; Solomon M; Ratjen F Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328 [TBL] [Abstract][Full Text] [Related]
3. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD; JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial. Ros M; Casciaro R; Lucca F; Troiani P; Salonini E; Favilli F; Quattrucci S; Sher D; Assael BM J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525 [TBL] [Abstract][Full Text] [Related]
5. Timing of hypertonic saline inhalation for cystic fibrosis. Elkins M; Dentice R Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770 [TBL] [Abstract][Full Text] [Related]
7. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Dellon EP; Donaldson SH; Johnson R; Davis SD Pediatr Pulmonol; 2008 Nov; 43(11):1100-1106. PubMed ID: 18828160 [TBL] [Abstract][Full Text] [Related]
9. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis. Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365 [TBL] [Abstract][Full Text] [Related]
10. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210 [TBL] [Abstract][Full Text] [Related]
11. [Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis]. Máiz Carro L; Lamas Ferreiro A; Ruiz de Valbuena Maiz M; Wagner Struwing C; Gabilondo Álvarez G; Suárez Cortina L Med Clin (Barc); 2012 Feb; 138(2):57-9. PubMed ID: 21511313 [TBL] [Abstract][Full Text] [Related]
12. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis. Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198 [TBL] [Abstract][Full Text] [Related]
19. A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomes. Donaldson SH; Danielle Samulski T; LaFave C; Zeman K; Wu J; Trimble A; Ceppe A; Bennett WD; Davis SD J Cyst Fibros; 2020 Nov; 19(6):942-948. PubMed ID: 32669217 [TBL] [Abstract][Full Text] [Related]
20. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]